A band of dissident Takeda shareholders outraged by CEO Christophe Weber’s plan to meld Shire into the fold through a $62 billion buyout has found a prominent spokesperson.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,